Dehydrated Alcohol Injection and Vimpat
Determining the interaction of Dehydrated Alcohol Injection and Vimpat and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of central nervous system (CNS)-active agents. Use in combination may result in additive CNS depression and/or impairment of judgment, thinking, and psychomotor skills. MANAGEMENT: Patients receiving CNS-active agents should be advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled against driving, operating machinery, or engaging in potentially hazardous activities requiring mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities. References Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990): Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7 Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc, Rockville, MD. "Product Information. Fycompa (perampanel)." Eisai Inc, Teaneck, NJ. View all 5 references
Professional:GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of central nervous system (CNS)-active agents. Use in combination may result in additive CNS depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Patients receiving CNS-active agents should be advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled against driving, operating machinery, or engaging in potentially hazardous activities requiring mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
- Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):
- Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc, Rockville, MD.
- "Product Information. Fycompa (perampanel)." Eisai Inc, Teaneck, NJ.
Generic Name: ethanol
Brand name: Ablysinol
Synonyms: Alcohol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dehydrated Alcohol Injection-Vimpat (Lacosamide Injection)
- Dehydrated Alcohol Injection-Vimpat (Lacosamide Oral Solution)
- Dehydrated Alcohol Injection-Vimpat (Lacosamide Tablets)
- Dehydrated Alcohol Injection-Vimpat Intravenous
- Dehydrated Alcohol Injection-Vimpat Oral Solution
- Dehydrated Alcohol Injection-Vinacal
- Vimpat-Dekpak 13 Day Taperpak
- Vimpat-Del-Beta
- Vimpat-Delacort
- Vimpat-Delafloxacin
- Vimpat-Delafloxacin Injection
- Vimpat-Delafloxacin Intravenous